CellFE, a leader in non-viral gene editing technology, today announced a strategic collaboration with the Harbottle Lab at ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

Pacira BioSciences has announced that its gene therapy candidate, PCRX-201 (enekinragene inzadenovec), has demonstrated ...

Learn how gene therapy is revolutionising the treatment of haemophilia a genetic disorder that affects blood clotting ...

Abeona Therapeutics Inc.’s ABEO share price has surged by 6.60%, which has investors questioning if this is right time to ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

New solutions support high-precision analytics for process development, batch release, and regulatory compliance.

Explore gene therapy advancements with Chromatin Bioscience's innovative chromatinLENS platform for safer, more effective treatments.